Associate Professor, Division Chief of Female Urology
University of California Irvine
Orange, California, United States
Dr. Olivia Chang is an Associate Professor of Clinical Urology and OB/GYN at UC-Irvine. She is the Chief of Female Urology, Pelvic Reconstructive Surgery and Voiding Dysfunction in the Department of Urology. She received her medical doctor degree from Tulane University School of Medicine and her Masters in Public Health at Mount Sinai School of Medicine. She completed her OB/GYN residency at Beth Israel Deaconess Medical Center at Harvard Medical School. After residency, she worked as an ob/gyn in sub-Saharan Africa and was the academic residency director for the OB/GYN residency program at the University of Malawi School of Medicine. Following her return to the United States, she completed a Female Pelvic Medicine and Reconstructive Surgery fellowship at the Cleveland Clinic.
She was in the 3rd cohort of the popular AUGS UrogynCREST program. She has a KL-2 grant for the development of personalized treatment of neurogenic bladder in patients with multiple sclerosis utilizing machine learning and artificial intelligence. She has published over 50 peer-reviewed articles and 4 book chapters. She has her own lab at UCI– the Center for Pelvic Floor Disorders Research – with a committed focus on the impact of hysterectomy and hysteropexy on pelvic floor disorders, patients' views of uterine preservation, and utilizing AI in treatment of pelvic floor disorders.
Diagnostic and Operative Flexible Cystoscopy - Reviewing technique and tips and tricks
Wednesday, October 23, 2024
8:10 AM – 8:30 AM EDT
Disclosure(s): No financial relationships to disclose
Wednesday, October 23, 2024
10:10 AM – 10:40 AM EDT
Disclosure(s): No financial relationships to disclose
Retreatment After Pelvic Organ Prolapse Surgery with Hysterectomy vs Hysteropexy
Wednesday, October 23, 2024
3:35 PM – 3:45 PM EDT
Disclosure(s): No financial relationships to disclose
OnabotulinumtoxinA for OAB via 1 vs 10 Injections: A Randomized Clinical Trial
Thursday, October 24, 2024
8:49 AM – 8:53 AM EDT
Disclosure(s): No financial relationships to disclose
Postoperative Activity Restrictions After Reconstructive Pelvic Surgery
Thursday, October 24, 2024
8:53 AM – 8:57 AM EDT
Disclosure(s): No financial relationships to disclose
Mini State of the Art: Hysteropexy - Current Practices and Emerging Trends
Friday, October 25, 2024
8:00 AM – 8:20 AM EDT
Disclosure(s): No financial relationships to disclose